Artal Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,133,775
| Closed | -$884K | – | 92 |
|
|
2023
Q3 | $884K | Hold |
1,133,775
| – | – | 0.04% | 76 |
|
|
2023
Q2 | $1.05M | Buy |
+1,133,775
| New | +$1.05M | 0.03% | 88 |
|
|
2018
Q1 | – | Sell |
-700,000
| Closed | -$4.68M | – | 83 |
|
|
2017
Q4 | $4.68M | Buy |
700,000
+200,000
| +40% | +$1.34M | 0.07% | 40 |
|
|
2017
Q3 | $4.1M | Buy |
500,000
+200,000
| +67% | +$1.64M | 0.07% | 42 |
|
|
2017
Q2 | $1.35M | Hold |
300,000
| – | – | 0.02% | 73 |
|
|
2017
Q1 | $1.65M | Hold |
300,000
| – | – | 0.04% | 63 |
|
|
2016
Q4 | $1.22M | Buy |
300,000
+100,000
| +50% | +$405K | 0.03% | 54 |
|
|
2016
Q3 | $1.41M | Buy |
+200,000
| New | +$1.41M | 0.03% | 61 |
|